Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
|
CN |
|
Sadhana Nitro Chem Ltd
BSE:506642
|
IN |
|
W
|
Westwing Comercio Varejista SA
BOVESPA:WEST3
|
BR |
|
Ihlas Gayrimenkul Proje Gelistirme ve Ticaret AS
IST:IHLGM.E
|
TR |
|
Heartland Group Holdings Ltd
NZX:HGH
|
NZ |
|
Honkarakenne Oyj
LSE:0EPR
|
FI |
Wuhan Hvsen Biotechnology Co Ltd
HVSEN Biotechnology Co., Ltd. engages in the research and development, production, and sale of veterinary drugs. The company is headquartered in Wuhan, Hubei and currently employs 828 full-time employees. The company went IPO on 2020-08-24. The Company’s main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The firm mainly conducts its businesses in the China market.
HVSEN Biotechnology Co., Ltd. engages in the research and development, production, and sale of veterinary drugs. The company is headquartered in Wuhan, Hubei and currently employs 828 full-time employees. The company went IPO on 2020-08-24. The Company’s main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The firm mainly conducts its businesses in the China market.
